The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's (IGC-AD1-P2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05543681
Recruitment Status : Recruiting
First Posted : September 16, 2022
Last Update Posted : January 8, 2024
Information provided by (Responsible Party):
India Globalization Capital Inc ( IGC Pharma LLC )

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 30, 2025
Estimated Study Completion Date : June 30, 2025